Market Overview:
The global retinal surgery devices market size reached US$ 1.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2027, exhibiting a growth rate (CAGR) of 7.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Retinal surgery devices refer to various equipment and accessories used for surgically repairing torn or detached retinas. These devices are usually manufactured using stainless steel and medical-grade silicon for enhanced sterility. Vitrectomy machines, scissors, lasers, tamponades, probes and light pipes are the most commonly used retinal surgery devices. They are primarily used in procedures for treating complications related to the retina, macula and vitreous fluid. Apart from this, these devices are also used during diabetic retinopathy and other ophthalmic procedures.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
The increasing prevalence of retinitis pigmentosa, macular degeneration and diabetic retinopathy currently represent as the key factors driving the growth of the market. The growing geriatric population that suffer from various age-related eye disorders, such as glaucoma, cataract and presbyopia, which can cause loss of vision, is also providing a boost to the market growth. There is widespread adoption of minimally invasive (MI) surgical procedures for the treatment of these diseases that offer various benefits, including minimal pain and discomfort, minor scarring and quick recovery. The development of innovative surgical devices is further creating a positive outlook for the market growth. Manufacturers are developing product variants that are equipped with fundus imaging units, micro-incision technology and endoillumination systems to enhance intraoperative efficiency, visualization and control. Other factors, including increasing awareness among the masses for various vision care procedures, developments in the healthcare sector and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global retinal surgery devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on equipment type, application and end-use.
Breakup by Equipment Type:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Vitrectomy Machines
- Retinal Laser Equipment
- Surgical Instruments
- Cannulas
- Forceps
- Cutters
- Cryoprobes
- Others
Breakup by Application:
- Diabetic Retinopathy
- Retinal Detachment
- Others
Breakup by End-Use:
- Hospitals
- Ophthalmology Clinics
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Alcon Management S. A., Bausch & Lomb Incorporated, Carl Zeiss, Ellex Medical Lasers, Erbe Elektromedizin, Escalon Medicals, Iridex Corporation, Leica Microsystems GmbH, Lumenis, Nidek Co. Ltd., Optos PLC, Second Sigh Medical Products, Synergetics USA Inc., Topcon Corporation, etc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Billion |
Segment Coverage |
Equipment Type, Application, End-Use, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Alcon Management S. A., Bausch & Lomb Incorporated, Carl Zeiss, Ellex Medical Lasers, Erbe Elektromedizin, Escalon Medicals, Iridex Corporation, Leica Microsystems GmbH, Lumenis, Nidek Co. Ltd., Optos PLC, Second Sigh Medical Products, Synergetics USA Inc. and Topcon Corporation |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global retinal surgery devices market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global retinal surgery devices market?
- What is the breakup of the market based on the equipment type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global retinal surgery devices market and who are the key players?
- What is the degree of competition in the industry?